Safar Partners

Activity from announced rounds

All recorded activity
Rounds participated in
8
Confirmed lead rounds
0
6 roles undisclosed
New companies
8
First participation on record · 0 follow-on
Funding in participating rounds
$1.3B
7 disclosed · full round size, not this investor’s share

By stage

Series B3
Series A2
Seed1
Series C+1
Undisclosed1

By primary sector

Climate tech5
Biotech2
Hardware1

By country

United States8

Rounds

8 in all activity
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Quintessent

Makes quantum dot laser chips for AI datacenter optical interconnects

$40MSeries A
Role not disclosed
Quaise Energy

Quaise Energy develops millimetre-wave drilling technology and geothermal power projects designed to access heat in deep, superhot rock.

$134MSeries B
Role not disclosed
Gradiant

Provides advanced water and wastewater treatment solutions for AI, semiconductor, and industrial sectors

UndisclosedSeries E
Role not disclosed
Via Separations

Electrifies chemical separations with modular filtration systems

$36MUndisclosed
Role not disclosed
GelMEDIX

Develops regenerative therapies to restore vision by regenerating damaged retinal cells

$13MSeed
Role not disclosed
Alva Energy

Developer of standardized upgrades that increase output from existing nuclear power plants.

$33MSeries A
Role not disclosed